The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...

The power of artificial intelligence (AI) and advanced computing has made it possible to design genetic sequences encoding ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...

Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...

The license enables Bionova to integrate the Clean Genome strain into its pDNA production workflows to support client programs.

MIT scientists may have just discovered how to reboot the aging immune system! By injecting older mice with specially ...

Three people, including two children, died of measles in the United States in 2025. Their deaths were preventable. There were ...

The global phosphoramidite market size was valued at USD 1.29 billion in 2025 and is predicted to hit around USD 2.45 billion ...

Hologic has received the US Food and Drug Administration (FDA) approval for its Aptima HPV assay for use in clinician-collected primary screening, further expanding its cervical health portfolio.

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.